Tuesday, April 23, 2024
56.4 F
Oxnard
More

    Latest Posts

    The Road to Tyranny by Don Jans

    Polls Say Millions of Americans Will Refuse COVID-19 Vaccine

    BY TOM OZIMEK

    As the race to develop a COVID-19 vaccine continues, polls show that when scientists do finally deliver, millions of Americans will refuse to take it.

    President Donald Trump told Fox News recently that he was confident that around the end of the year, a vaccine would be available for COVID-19, the disease caused by the Chinese Communist Party (CCP) virus, commonly known as the novel coronavirus.

    Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and member of the White House coronavirus task force, gave a similar estimate for the availability of such a vaccine, when on April 30 he announced one would be ready by January 2021.

    But even when a COVID-19 vaccine is ready, a roadblock on the path to building herd immunity is that around 14 percent of Americans say they won’t get one, according to a poll by Morning Consult.

    The survey, conducted May 1-3 on a sample of 2,200 U.S. adults, also shows that 64 percent of Americans said they would get the vaccine, while 22 percent said they didn’t have an opinion on the subject or were undecided.

    Further, according to Morning Consult, the age group most likely to say no to a vaccine are people between 35 and 44. Only 53 percent of Americans in this age group said they would get a COVID-19 vaccine when one becomes available, while 18 percent said they would not.

    According to Kristin Lunz Trujillo and Matt Motta, coauthors of a pre-print study into vaccine attitudes, some estimates show that between 50-70 percent of Americans would need to develop immunity to COVID-19, either naturally, or by way of a vaccine, in order to stop the pandemic in its tracks.

    Meanwhile, drugmaker Moderna has obtained clearance from the Food and Drug Administration to run a larger trial of its COVID-19 vaccine candidate.

    The state of the phase two trial is “imminent,” Moderna CEO Stéphane Bancel said in a statement.

    The trial will include 600 participants. The biotechnology company said the trial will include 600 participants and that it hopes to start a phase three study as early as this summer.

    There are no vaccines or proven treatments for the CCP virus or COVID-19.

    The virus primarily causes severe illness in the elderly and those with underlying health conditions.

    A significant number of people who become infected never show symptoms while others experience mild or moderate symptoms.

    Symptoms include fever, fatigue, chills, as well as aches and pains.

    Follow Tom on Twitter: @OZImekTOM

    Republished with Permission The Epoch Times    SUBSCRIBE


    Get Citizensjournal.us Headlines free  SUBSCRIPTION. Keep us publishing – DONATE

    - Advertisement -
    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest

    0 Comments
    Inline Feedbacks
    View all comments

    Latest Posts

    advertisement

    Don't Miss

    Subscribe

    To receive the news in your inbox

    0
    Would love your thoughts, please comment.x
    ()
    x